Login / Register
Menu
About us
Products
Primary antibodies
Gallery
Distributors
Validation
Tissue Microarrays
Publications
Large Scale Studies
Further Publications
Events
Quiz
Contact
About us
Products
Primary antibodies
Gallery
Distributors
Validation
Tissue Microarrays
Publications
Large Scale Studies
Further Publications
Events
Quiz
Contact
Search
×
Cancer Tissue Gallery CEA
Path
Created with Sketch.
Go to CEA Normal Tissue Gallery
Go back to Product Page
Adenocarcinoma of the lung showing strong CEA immunostaining in tumor cells.
Adenocarcinoma of the lung showing strong CEA immunostaining in tumor cells.
Adenocarcinoma of the pancreas with strong CEA immunostaining in all tumor cells.
Adenocarcinoma of the pancreas with strong CEA immunostaining in all tumor cells.
Cholangiocellular carcinoma of the liver showing strong CEA immunostaining in tumor cells.
Cholangiocellular carcinoma of the liver showing strong CEA immunostaining in tumor cells.
Colorectal adenocarcinoma with strong CEA positivity in tumor cells.
Colorectal adenocarcinoma with strong CEA positivity in tumor cells.
Diffuse type stomach cancer with strong CEA immunostaining of all tumor cells.
Diffuse type stomach cancer with strong CEA immunostaining of all tumor cells.
Hepatocellular carcinoma completely lacking CEA immunostaining.
Hepatocellular carcinoma completely lacking CEA immunostaining.
Intestinal type stomach cancer with moderate to strong CEA immunostaining of tumor cells.
Intestinal type stomach cancer with moderate to strong CEA immunostaining of tumor cells.
Malignant mesothelioma not showing any CEA immunostaining.
Malignant mesothelioma not showing any CEA immunostaining.
Medullary thyroid cancer with strong CEA immunostaining in all tumor cells.
Medullary thyroid cancer with strong CEA immunostaining in all tumor cells.
Moderate to strong CEA positivity in a mucinous carcinoma of the ovary.
Moderate to strong CEA positivity in a mucinous carcinoma of the ovary.
Strong CEA immunostaining in <50% of cells of a squamous cell carcinoma of the larynx.
Strong CEA immunostaining in <50% of cells of a squamous cell carcinoma of the larynx.
Strong CEA immunostaining in about 60% of cells of a squamous cell carcinoma of the larynx.
Strong CEA immunostaining in about 60% of cells of a squamous cell carcinoma of the larynx.
Strong CEA immunostaining in about 80% of cells of a squamous cell carcinoma of the uterine cervix.
Strong CEA immunostaining in about 80% of cells of a squamous cell carcinoma of the uterine cervix.
Weak to moderate CEA immunostaining in a lobular breast cancer.
Weak to moderate CEA immunostaining in a lobular breast cancer.